PARIS REGION: A FOCUS ON HEALTH
The Paris Region is ideally positioned in medical innovation in Europe, and is showing unprecedented strength and drive in the development of digital health services.
Did you know? Half of all life sciences research in France is done at laboratories and hospitals in Île-de-France. Paris Region is the leading European region for pharmaceuticals and has the largest hospital system in Europe. In addition, four of the world's 15 most innovative research bodies are in Île-de-France. Beyond the figures, this excellence attracts global businesses. "We chose France for the skills of its doctors and the quality of its hospital structures," It's also a country that works a lot on future advances says Frédérique Fauduet, head of clinical operations in France for the American company Pharm-Olam, which has a location in Paris.
WORLD-CLASS RESEARCH IN ONCOLOGY, CARDIOLOGY, NEUROLOGY IS GOING ON IN PARIS REGION
Christian Lajoux, President of Medicen Paris Region, confirms: "The work going on in Île-de-France in oncology, cell and gene therapy, regenerative treatments, cardiology, neurology, and infectious diseases is among the most advanced in the world".
Half of the units of Inserm, an organization which leads European patent applicants for biotech, are located in Île-de-France. The Region also contains most of the life science activities of the CEA, whose medical imaging platform in Paris-Saclay is unequaled anywhere else. In particular, the NeuroSpin high-field neuroimaging center is one of a kind. The CNRS; the Pasteur Institute, a foundation that seeks to treat infectious diseases, the Curie Institute, a leader in the fight against cancer; the Gustave Roussy Institute, an expertise cluster devoted to cancer patients; as well as nine universities, two teacher-training colleges, and multiple schools of engineering all form part of the life sciences research landscape in Paris Region.
PARIS REGION FIRST IN EUROPE IN NUMBER OF PHARMA COMPANIES
Île-de-France is also France's leading region in clinical trials. 90% of businesses that carry on business in this sector in France are based there. Every year, hundreds of clinical trials are conducted in Paris Region on cancer, rare illnesses, and infectious diseases. The AP-HP university hospital center, with its 39 hospitals and 100,000 health care professionals, is home to four clinical experimentation centers, which carried out 3100 projects in 2016. Another way in which Paris Region is a leader - on the European level this time - is in hosting the most pharmaceutical groups. In all, there are 202 establishments, including Astra Zeneca, Bristol-Myers Squibb, GlaxoSmithKline, Guerbet, Lilly, Novartis, Pfizer, Roche, and Sanofi. Several of them have decided to base their R&D centers in Île-de-France. Additionally, Servier plans to have one in Paris-Saclay by 2021, and Sanofi just opened its open innovation lab devoted entirely to e-health, in Gentilly.
DIGITAL HEALTH CARE IN THE HEART OF PARIS REGION
Let's talk e-health! "The arrival of digital technology to health care makes the Region all the more attractive," says Christian Lajoux. Start-ups located in Ile-de-France have developed applications that facilitate relations between patients and health professionals. They include Doctolib, Instacare, DoudouCare, Epiderm, and others. In cancer research, the Curie Institute is supporting Appli Chimio, a home monitoring project for patients undergoing chemotherapy. Paris Region has invested directly in the deployment of the TERR-eSANTE platform to combine improved health in Île-de-France with the growth of the digital economy. Internationally, Paris Region's talent in digital health is well-known: The American magazine MIT Technology Review counted three French start-ups among the most innovative in health tech, including Doctolib. This recognition attracts innovative foreign companies and has led them to join the Ile-de-France ecosystem. The global group General Electric Healthcare set up its Paris R&D center, Digital Foundry in 2016. Then there are the many start-ups that call Paris Region home, like MedClinik, a subsidiary of the Canadian Group 360Medlink. In 2016, there were 52 job-creating foreign investment projects within the health care industry in France.
PARIS REGION, A POWERFUL HEALTHCARE CLUSTER
The development of medtech in Île-de-France is boosted by the large number of research disciplines in the Region. Doctors cross paths with engineers; Inserm shares projects with INRIA. To encourage cooperation, business clusters like Medicen, Cap Digital, and Systematic are among the assets of Paris Region. "We are catalysts, who foster encounters between private and public players," according to Christian Lajoux, "and integrators, who work directly with Paris Region to call out pointless competition and arrange synergies. ." By hosting innovative project leaders, incubators such as Agoranov, Incuballiance, and Paris Biotech Santé also play key roles in the success of e-Health. The Lab Santé Île-de-France, founded by the Paris Île-de-France CCI and Medicen, has pioneered this model, as a mediating structure between innovation providers and users. The goal? Supporting entrepreneurs whose innovative ideals are the most useful in health care.
Inserm – National Institute of Health and Medical Research
CNRS – National Center of Scientific Research
CEA – Atomic and Alternative Energy Commission
AP-HP – Public Assistance – Hospitals of Paris
INRIA - National Institute of Research into Information Technology and Automation
MedTech - businesses in the medical technology sector
CCI – Chamber of Commerce and Industry